GPT and cholangitis: At 3 and 6 months of follow-up, in the mild cholangitis group, there was no significant difference of NLS, recurrence rate, jaundice clearance rate, ALT, AST, γ-GGT, and DBIL between the patients treated with CSTS or MEPM (all P>0.05) (Table 6).